These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
886 related articles for article (PubMed ID: 22105368)
21. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer. Chen W; Gao N; Shen Y; Cen JN J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341 [TBL] [Abstract][Full Text] [Related]
22. Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A. Cao L; Wang S; Zhang Y; Wong KC; Nakatsu G; Wang X; Wong S; Ji J; Yu J Oncogene; 2018 Jun; 37(26):3601-3616. PubMed ID: 29610526 [TBL] [Abstract][Full Text] [Related]
23. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis. Shin SH; Park SY; Kang GH Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999 [TBL] [Abstract][Full Text] [Related]
24. Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation. Li X; Huang J; Luo X; Yang D; Yin X; Peng W; Bi C; Ren G; Xiang T Int J Biol Sci; 2018; 14(12):1686-1695. PubMed ID: 30416383 [TBL] [Abstract][Full Text] [Related]
25. Dapper homolog 1 is a novel tumor suppressor in gastric cancer through inhibiting the nuclear factor-κB signaling pathway. Wang S; Kang W; Go MY; Tong JH; Li L; Zhang N; Tao Q; Li X; To KF; Sung JJ; Yu J Mol Med; 2012 Dec; 18(1):1402-11. PubMed ID: 23073659 [TBL] [Abstract][Full Text] [Related]
26. Applicability of the methylated CpG sites of paired box 5 (PAX5) promoter for prediction the prognosis of gastric cancer. Deng J; Liang H; Zhang R; Dong Q; Hou Y; Yu J; Fan D; Hao X Oncotarget; 2014 Sep; 5(17):7420-30. PubMed ID: 25277182 [TBL] [Abstract][Full Text] [Related]
27. Low expression of fibulin-1 correlates with unfavorable prognosis in gastric cancer. Feng L; Yao C; Li P; Feng Y; Wang F; Liu YF; Guo YB; Mao QS; Xue WJ Tumour Biol; 2016 Jul; 37(7):9399-410. PubMed ID: 26779638 [TBL] [Abstract][Full Text] [Related]
28. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers. Hu X; Sui X; Li L; Huang X; Rong R; Su X; Shi Q; Mo L; Shu X; Kuang Y; Tao Q; He C J Pathol; 2013 Jan; 229(1):62-73. PubMed ID: 22926751 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic efficacy of SEPT9 and PAX5 gene methylation in gastrointestinal cancer and precancerous lesions. Yan Z; Liu H; Wang K Cell Mol Biol (Noisy-le-grand); 2024 Jul; 70(7):128-133. PubMed ID: 39097885 [TBL] [Abstract][Full Text] [Related]
30. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome. Ma G; Liu H; Hua Q; Wang M; Du M; Lin Y; Ge Y; Gong W; Zhao Q; Qiang F; Tao G; Zhang Z; Chu H Mol Cancer; 2017 Feb; 16(1):46. PubMed ID: 28231797 [TBL] [Abstract][Full Text] [Related]
31. Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer. Zhu XJ; Liu J; Xu XY; Zhang CD; Dai DQ Mol Med Rep; 2014 Jun; 9(6):2283-92. PubMed ID: 24718752 [TBL] [Abstract][Full Text] [Related]
32. LUCAT1 Epigenetically Downregulates the Tumor Suppressor Genes Byun HJ; Yoon JH; Lee SK Yonsei Med J; 2020 Nov; 61(11):923-934. PubMed ID: 33107235 [TBL] [Abstract][Full Text] [Related]
33. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53. Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients. Chen YJ; Wu H; Zhu JM; Li XD; Luo SW; Dong L; Liu TT; Shen XZ J Gastroenterol Hepatol; 2016 Jan; 31(1):155-63. PubMed ID: 26173586 [TBL] [Abstract][Full Text] [Related]
35. LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer. Liu WB; Jiang X; Han F; Li YH; Chen HQ; Liu Y; Cao J; Liu JY Cell Death Dis; 2013 Oct; 4(10):e882. PubMed ID: 24157876 [TBL] [Abstract][Full Text] [Related]
36. DNA damage-inducible gene, reprimo functions as a tumor suppressor and is suppressed by promoter methylation in gastric cancer. Ooki A; Yamashita K; Yamaguchi K; Mondal A; Nishimiya H; Watanabe M Mol Cancer Res; 2013 Nov; 11(11):1362-74. PubMed ID: 23982217 [TBL] [Abstract][Full Text] [Related]
37. Epigenetic inactivation of FAT4 contributes to gastric field cancerization. Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292 [TBL] [Abstract][Full Text] [Related]
38. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674 [TBL] [Abstract][Full Text] [Related]
39. ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5. Seo EH; Kim HJ; Kim JH; Lim B; Park JL; Kim SY; Lee SI; Jeong HY; Song KS; Kim YS Int J Cancer; 2020 Jun; 146(12):3354-3368. PubMed ID: 32129880 [TBL] [Abstract][Full Text] [Related]
40. Frequent silencing of protocadherin 8 by promoter methylation, a candidate tumor suppressor for human gastric cancer. Zhang D; Zhao W; Liao X; Bi T; Li H; Che X Oncol Rep; 2012 Nov; 28(5):1785-91. PubMed ID: 22941331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]